Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra(TM) in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders

NCT00118495 is registered in ClinicalTrials.gov with QualiLife Pharmaceuticals as lead sponsor.

NCT NCT00118495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00118495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra(TM) in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders
Lead sponsor
QualiLife Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
March 31, 2007
Enrollment
200
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

sexual dysfunction, psychological